Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study

Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia

(2011) Philipp Schuetz et al.   INTENSIVE CARE MEDICINE

Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis

(2011) James D. Chalmers et al.   INTENSIVE CARE MEDICINE

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

(2011) Sabine CA Meijvis et al.   LANCET

Cardiovascular and Inflammatory Biomarkers to Predict Short- and Long-Term Survival in Community-acquired Pneumonia

(2010) Stefan Krüger et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy of Corticosteroids in Community-acquired Pneumonia

(2010) Dominic Snijders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Assessment of inflammatory markers in patients with community-acquired pneumonia — Influence of antimicrobial pre-treatment

(2010) Stefan Krüger et al.   CLINICA CHIMICA ACTA

Prognostic value of N-terminal pro-brain natriuretic peptide in hospitalised patients with community-acquired pneumonia

(2010) K. Y. Jeong et al.   EMERGENCY MEDICINE JOURNAL

Adrenal function is related to prognosis in moderate community-acquired pneumonia

(2010) M. Kolditz et al.   EUROPEAN RESPIRATORY JOURNAL

Towards a sensible comprehension of severe community-acquired pneumonia

(2010) Santiago Ewig et al.   INTENSIVE CARE MEDICINE

Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ

(2010) S. Kruger et al.   THORAX

Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis

(2010) Y. K. Loke et al.   THORAX

Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis

(2010) J. D. Chalmers et al.   THORAX

Late Admission to the ICU in Patients With Community-Acquired Pneumonia Is Associated With Higher Mortality

(2009) Marcos I. Restrepo et al.   CHEST

Severe Community‐Acquired Pneumonia: Validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission

(2009) Adamantia Liapikou et al.   CLINICAL INFECTIOUS DISEASES

Association between timing of intensive care unit admission and outcomes for emergency department patients with community-acquired pneumonia*

(2009) Bertrand Renaud et al.   CRITICAL CARE MEDICINE

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ

(2009) S. Kruger et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

(2009) R Menendez et al.   THORAX

Risk Prediction With Procalcitonin and Clinical Rules in Community-Acquired Pneumonia

(2008) David T. Huang et al.   ANNALS OF EMERGENCY MEDICINE

SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia

(2008) Patrick G. P. Charles et al.   CLINICAL INFECTIOUS DISEASES

Adrenal function in patients with community-acquired pneumonia

(2008) S. Gotoh et al.   EUROPEAN RESPIRATORY JOURNAL

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment

(2008) H. Kothe et al.   EUROPEAN RESPIRATORY JOURNAL

CRB-65 for the assessment of pneumonia severity: who could ask for more?

(2008) S. Ewig et al.   THORAX

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

(2007) S. Kruger et al.   EUROPEAN RESPIRATORY JOURNAL